Javascript must be enabled to continue!
For how long should oxytocin be continued during induction of labour?
View through CrossRef
Objective To answer the question of whether oxytocin induction of labour should be discontinued when active labour begins.Design We enrolled patients admitted for induction of labour with oxytocin. Exclusion criteria for induction of labour included non‐vertex presentation, past history of more than one caesarean delivery, multiple pregnancies, persistent non‐reassuring fetal heart rate before induction of labour and estimated fetal weight of more than 4250 g.Setting Department of Obstetrics and Gynecology, Ha'Emek Medical Center, Afula, Israel.Population Patients who were admitted for induction of labour in Ha'Emek Medical Center from 1st February 1998 to 29th February 2000.Methods Patients were randomly divided into two groups. In group A, infusion of oxytocin was incremental until 5 cm dilation and maintained at the same level from that point throughout the labour. In group B, infusion of oxytocin was incremental but was discontinued when cervical dilatation reached 5 cm. Comparison between the two groups was made using Wilcoxon rank‐sum test and Fisher's exact test.Main outcome measure Primary outcome variable was duration from induction to delivery. The secondary outcome variables included: duration of labour stages, maximal dosage and total amount of oxytocin used, the use of analgesia, abnormalities in fetal heart rate and episodes of uterine hyperstimulation. We also recorded mode of delivery, together with maternal and neonatal outcome.Results One hundred and four patients participated in this study. The active phase of labour was shorter in group B compared with group A, but this difference was not statistically significant (2.6 ± 2 vs 3.3 ± 2.9, P= 0.07). In group A there were six caesarean deliveries and in group B only three. No significant differences were found when the other outcome parameters were compared.Conclusions There is no advantage in continuing oxytocin infusion after the onset of active labour.
Title: For how long should oxytocin be continued during induction of labour?
Description:
Objective To answer the question of whether oxytocin induction of labour should be discontinued when active labour begins.
Design We enrolled patients admitted for induction of labour with oxytocin.
Exclusion criteria for induction of labour included non‐vertex presentation, past history of more than one caesarean delivery, multiple pregnancies, persistent non‐reassuring fetal heart rate before induction of labour and estimated fetal weight of more than 4250 g.
Setting Department of Obstetrics and Gynecology, Ha'Emek Medical Center, Afula, Israel.
Population Patients who were admitted for induction of labour in Ha'Emek Medical Center from 1st February 1998 to 29th February 2000.
Methods Patients were randomly divided into two groups.
In group A, infusion of oxytocin was incremental until 5 cm dilation and maintained at the same level from that point throughout the labour.
In group B, infusion of oxytocin was incremental but was discontinued when cervical dilatation reached 5 cm.
Comparison between the two groups was made using Wilcoxon rank‐sum test and Fisher's exact test.
Main outcome measure Primary outcome variable was duration from induction to delivery.
The secondary outcome variables included: duration of labour stages, maximal dosage and total amount of oxytocin used, the use of analgesia, abnormalities in fetal heart rate and episodes of uterine hyperstimulation.
We also recorded mode of delivery, together with maternal and neonatal outcome.
Results One hundred and four patients participated in this study.
The active phase of labour was shorter in group B compared with group A, but this difference was not statistically significant (2.
6 ± 2 vs 3.
3 ± 2.
9, P= 0.
07).
In group A there were six caesarean deliveries and in group B only three.
No significant differences were found when the other outcome parameters were compared.
Conclusions There is no advantage in continuing oxytocin infusion after the onset of active labour.
Related Results
Patterns of oxytocin use for induction and augmentation of labour among healthcare providers in Nigeria
Patterns of oxytocin use for induction and augmentation of labour among healthcare providers in Nigeria
Abstract
Background
The practice of intrapartum use of oxytocin for induction and augmentation of labour is increasing worldwide with documented wid...
024 Quiescent Wakefulness: Characterising the Impact of Oxytocin on Sleep-Wake Behaviour in Male and Female Rats
024 Quiescent Wakefulness: Characterising the Impact of Oxytocin on Sleep-Wake Behaviour in Male and Female Rats
Abstract
Introduction
Oxytocin is a versatile hypothalamic neuropeptide involved in diverse neurobehavioural processes. Since ox...
Oxytocin Released within the Supraoptic Nucleus of the Rat Brain by Positive Feedback Action is Involved in Parturition‐Related Events
Oxytocin Released within the Supraoptic Nucleus of the Rat Brain by Positive Feedback Action is Involved in Parturition‐Related Events
Oxytocin is released within the supraoptic nucleus during parturition and suckling. During suckling, such release is important in positive feedback stimulation of oxytocin neurons....
Comparison of the Effectiveness of 5 IU Oxytocin Bolus and 20 IU Infusion on Uterine Contraction and Hemodynamic Response in Caesarean Section
Comparison of the Effectiveness of 5 IU Oxytocin Bolus and 20 IU Infusion on Uterine Contraction and Hemodynamic Response in Caesarean Section
Uterine atonic can result in postpartum hemorrhage, gravid hysterectomy andmaternal mortality. Oxytocin is the most commonly used agent for the preventionand treatment of atonic ut...
Prevention of prolonged labour in term nulliparas with oxytocin alone versus with oxytocin and an antispasmodic
Prevention of prolonged labour in term nulliparas with oxytocin alone versus with oxytocin and an antispasmodic
Background: Poor progress of labour is a common problem with nulliparous deliveries. It occurs when the cervical dilatation rate in the active phase of the first stage of labour is...
Quiet wakefulness: The influence of intraperitoneal and intranasal oxytocin on sleep-wake behaviour and neurophysiology in rats
Quiet wakefulness: The influence of intraperitoneal and intranasal oxytocin on sleep-wake behaviour and neurophysiology in rats
AbstractIntroductionExogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobehavioural processes, including sleep and wakefulness. Since oxyto...
Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
Quiet wakefulness: the influence of intraperitoneal and intranasal oxytocin on sleep–wake behavior and neurophysiology in rats
Abstract
Study Objectives
Exogenous administration of the neuropeptide oxytocin exerts diverse effects on various neurobe...
Comparative evaluation of the caesarean section rate in term nulliparas with labour dystocia following augmentation with oxytocin alone versus with oxytocin and drotaverine
Comparative evaluation of the caesarean section rate in term nulliparas with labour dystocia following augmentation with oxytocin alone versus with oxytocin and drotaverine
Background: Labour dystocia is the commonest indication for emergency caesarean section in nulliparas, and occurs when the progress of labour is abnormally slow. Labour dystocia ma...

